News
US FDA Launches New Programme to Advance Neuroscience Innovation
The new programme will coordinate expertise across the FDA’s drug, biologics and medical device centres, with its first initiative focused on advancing clinical trials and drug development for Alzheimer’s prevention.
imphoenix82
- October 23, 2026
- 0 Comments
- 123 Views
-
